Tailoring Individualized Pharmacotherapy for Bipolar Disorder: How to Translate Findings from Clinical Trials to a Single Patient
Joseph F. Goldberg, MD
Practitioners are often unfamiliar with how to apply findings from the clinical trials literature in bipolar disorder (BD) to their own patients, or how to anticipate differences in treatment outcomes that involve research subjects vs “real world” patients. This session will review principles of evidence-based medicine as they apply to differential pharmacotherapy options for patients with BD. Participants will learn strategies that can enable them to apply findings from clinical trials to their own patients, and recognize core concepts for translating findings from the empirical literature to their own individual patients.
Does My Patient Have Bipolar Disorder? A Review of Diagnostic Concerns, Conundrums, and Confusion and What to Do About It
Mark Zimmerman, MD
The goal of this session is to educate clinicians as to the respective consequences of both underdiagnosis and overdiagnosis of bipolar disorder (BD). The impact of changes in the diagnostic criteria for BD in DSM-5 will be reviewed, including the addition of mixed features specifier. Dr. Zimmerman will highlight the conceptual and practical problems with the use of screening scales in clinical practice and will describe an alternative approach towards improving the validity of diagnosing BD in clinical practice.
Bipolar Disorders in Children and Adolescents: Recognition and Treatment Update
Kiki D. Chang, MD
Bipolar disorders (BD) occur in 1% to 2% of the youth population and carry high morbidity and mortality—even higher than adult-onset bipolar disorder. This session will provide up-to-date knowledge regarding the incidence and recognition of BD in youth. The latest treatment options, including psychotherapy and medications, will be reviewed. Finally, identification and prevention of BD in youth at high-risk will be considered.